Artículos del autor

solaci

Day 2

POLAR ACS: bio-absorbable platform in acute coronary syndromes

Bio-absorbable devices are considered safe and effective for stable patients but there is still little information regarding...

solaci - 24 June, 2015

Day 2

PRAGUE 19: bioabsorbable platform for patients with ST segment elevation

Absorbable bioplatforms are considered safe and effective in stable patients but their use in the context of...

solaci - 24 June, 2015

Day 2

PROMUS PREMIER: new everolimus-eluting stent

The study aims to evaluate clinical, angiographic and IVUS results of the new platinum chromium everolimus stent....

solaci - 24 June, 2015

Day 2

HATTRICK-OCT: biodegradable polymer struts coverage versus permanent

Late endothelialization of first generation pharmacological stents may predispose thrombosis. Both the drug and the polymer of...

solaci - 24 June, 2015

Day 1

SCAAR: Heparin versus bivalirudin in patients with myocardial infarction without ST segment elevation.

We evaluated 41,537 patients admitted with myocardial infarction without ST elevation on the SCAAR register and who...

solaci - 24 June, 2015

Day 1

SOURCE XT: Results of the latest generation of the Edwards valve

The first generation of the Edwards valve was stainless steel and bovine pericardium with a profile of...

solaci - 24 June, 2015

Day 1

EnligHTN: treatment of refractory hypertension by catheterization

Lowering blood pressure with renal denervation has been demonstrated in previous studies but unfortunately there was not...

solaci - 24 June, 2015

Day 2

CENTURY: new clinical results of sirolimus-eluting degradable polymer stent

This new stent is a sirolimus-eluting low-profile cobalt chrome platform (80 µm) with a rapid resorption polymer...

solaci - 24 June, 2015

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 22 June, 2026 0

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 19 June, 2026 0

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide. Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 17 June, 2026 0

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

Noticias Institucionales

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

solaci - 17 June, 2026 0

Share your experience. Learn from experts. Grow as an interventional cardiologist. A new edition of the Fellow’s Corner is here, an academic exchange space designed...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

solaci - 15 June, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

solaci - 10 June, 2026 0

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.